AzTrials
AzTrials

Intervention GroupNCT07486037

Caring for Caregivers of Individuals With Alzheimer's Disease

A study testing Exercise in people with Intervention Group and Treatment as Usual, run by Indiana University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

What is this study about? This study is called the EMBRACE Study - A Virtual Community Empowerment Approach Integrating Tradition and Technology for Family Caregivers of Individuals with Alzheimer's Disease. Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Intervention Group, Treatment as Usual
What is being tested?
Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteUnited States
Study dates
1 Mar 2026to 1 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Self-identifies as African American
  • Age 18 years or older
  • Primary unpaid caregiver for an adult living with Alzheimer's disease or a related dementia (ADRD)
  • Able to read and speak English
  • Deemed sufficiently healthy to participate in exercise per the PAR-Q+ screening questionnaire
  • Has access to an email address

Who cannot join

  • Diagnosed psychiatric illness
  • Untreated severe major depression
  • Currently receiving advanced cancer treatment or hospice care
  • Currently receiving dialysis
  • Severe hearing loss without hearing aids
  • Severe vision impairment without corrective eyeglasses
Show all 9Show fewer
  • No access to a phone or email
  • Unable to safely exercise based on PAR-Q+ screening
  • Already meeting the recommended physical activity guidelines at the time of enrollment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Navin Kaushal, PhD, FACM,FAHA contact

317 278-9598

nkaushal@iu.edu

United States1 site, 1 recruiting
  • School of Health and Human Sciences

    Indianapolis, Indiana, 46240

    Navin Kaushal, PhD, 3174505240, nkaushal@iu.edu

    Recruiting

Other trials in United States

About this study

Official title: Caring for Caregivers of Individuals With Alzheimer's Disease- Promoting Virtual Home-based Exercise for Caregiver Wellbeing

What is this study about? This study is called the EMBRACE Study - A Virtual Community Empowerment Approach Integrating Tradition and Technology for Family Caregivers of Individuals with Alzheimer's Disease. It tests whether a home-based virtual exercise program can reduce depression and anxiety in family caregivers of people living with Alzheimer's disease and related dementias (ADRD).

Why is this study needed? Caring for a loved one with ADRD is demanding and is strongly linked to depression and anxiety. Regular exercise is one of the most effective ways to reduce these symptoms - but caregivers often cannot leave home to exercise due to the needs of their loved one, transportation concerns, and safety issues.

Read more

What does participation involve? Participants will be randomly assigned (like a coin flip) to one of two groups:

  • EMBRACE group: 24 weekly virtual group exercise sessions over 3 months (about 1 hour each), using an at-home elliptical device provided by the study. Months 4-6 include weekly check-in calls to support independent exercise. Educational sessions on habit-building and goal-setting are included.
  • Wait-list control group: Completes the same surveys and measurements; receives the program after data collection ends.

Who can join? Adults (18+) who are the primary unpaid caregiver for someone with ADRD, can read and speak English, and are healthy enough to exercise. Participants do not need to leave home - everything is virtual.

What is being measured? Exercise time (using a wearable device), symptoms of depression and anxiety, and whether the program is feasible and acceptable to participants.

Where is the study based? Indiana University Indianapolis. The study is conducted entirely virtually and remotely.

Read the detailed description

Background and Rationale

As the U.S. population ages, the number of individuals living with Alzheimer's disease and related dementias (ADRD) is growing substantially. Family caregivers of adults with ADRD perform complex daily tasks, including activities of daily living, financial management, and medication management, yet are frequently unprepared for the scope of the role. ADRD caregiving is associated with significantly elevated rates of anxiety and depression compared to non-caregivers. Depression is the leading cause of disability worldwide, making the mental health of caregivers a critical public health concern.

Regular physical exercise is one of the most evidence-based strategies for preventing and alleviating depression and anxiety. However, rates of physical activity remain low nationwide, and research has shown that caregivers struggle to maintain exercise routines outside of controlled settings. Caregivers face unique barriers including the inability to leave their care recipient unattended, transportation burden, and unpredictable schedules. Home-based and virtual exercise programs have been identified as viable alternatives that bypass these barriers.

Study Purpose

The purpose of this Phase I randomized controlled trial is to test the feasibility, acceptability, and preliminary efficacy of the EMBRACE intervention - a theory-informed, home-based, virtual group exercise program tailored for family caregivers of individuals with ADRD.

Theoretical Framework

The EMBRACE intervention is grounded in Self-Determination Theory (SDT), which holds that sustained behavior change requires support for three basic psychological needs: autonomy (choosing when and how to exercise), competence (developing skills and knowledge), and relatedness (social connection with peers). The intervention further incorporates self-regulation strategies (goal-setting and planning) and habit formation principles to promote long-term independent exercise beyond the structured program period.

Intervention Structure

The EMBRACE program is delivered over 6 months in two phases:

Months 1-3 (Structured Phase): 24 weekly virtual group exercise sessions (~1 hour each), delivered in small groups of 6-7 participants across two daily time slots (morning and evening). Sessions follow a fixed structure: warm-up (5 min), cardiovascular exercise using a provided Cubii Total Body Elliptical (25 min), strength training (25 min), and cool-down (5 min). The first three sessions include theory-informed education modules on physical activity guidelines, habit formation, and exercise planning and goal-setting.

Months 4-6 (Independent Exercise Phase): Participants exercise independently, supported by weekly booster phone calls (5-10 min each) and weekly text message prompts functioning as behavioral habit cues.

Month 7: Exit focus groups are conducted to gather qualitative feedback on intervention facilitators and barriers.

All study equipment including a tablet, elliptical device, and accelerometer - is mailed to participants, enabling full remote participation.

Control Arm

Participants in the wait-list control arm complete all outcome measures at the same three time points as the intervention arm. The wait-list design is standard practice in behavioral trials involving caregivers and ensures participants eventually receive the program, which is ethically important given the established benefits of exercise for caregiver mental health.

Recruitment

Participants will be recruited through community-based advertising (churches, community centers) and patient referrals from the study's co-investigator geriatric psychiatrist. The study leverages an established community network developed through a related R24 project, including 12 local community leaders and over 300 newsletter recipients in Marion and Lake counties, Indiana.

Randomization and Blinding

Following baseline data collection, participants are randomized 1:1 to the EMBRACE or wait-list control arm. Data collectors administering outcome measures at all time points are blinded to group assignment.

Intervention Fidelity

Fidelity is maintained through standardized staff training, session recording with random fidelity checks using a structured quality assurance form, attendance tracking, and participant self-report exercise logs submitted via voice message.

Assistive Technology Component

To help caregivers carve out protected exercise time at home, the study incorporates multi-sensory assistive technologies designed to reduce disruptive or neuropsychiatric behaviors in individuals with dementia, thereby enabling caregivers to prioritize their own well-being during exercise sessions.

Future Directions

Findings from this Phase I trial will be used to refine the intervention and inform a Phase II efficacy trial. The investigators will also explore the feasibility of developing a concurrent caregiver-care recipient program.

Being tested
Exercise

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseBehavioural

    Participants will engage in home-based exercise

Study groups in NCT07486037
Study groupRoleWhat they receive
Experimental: EMBRACE Virtual Home-Based ExerciseExperimentalParticipants in the EMBRACE arm will receive a 6-month home-based virtual exercise program consisting of 24 weekly group exercise sessions (months 1-3) followed by a supported independent exercise phase (months 4-6). All equipment, including a Cubii Total Body Elliptical and tablet, will be mailed to participants so the program can be completed entirely from home. Theory-informed educational content on habit formation, goal-setting, and self-regulation is embedded in the first three sessions to support long-term independent exercise adherence.
Receives: Behavioral: Exercise
No Intervention: Wait-List ControlNo interventionParticipants in the wait-list control arm will complete all study outcome measures at the same three time points as the experimental arm (baseline, month 3, and month 6) but will not receive the EMBRACE intervention during the data collection period. This treatment-as-usual approach is standard practice in behavioral trials involving caregivers and allows for a clean comparison of outcomes between groups. Upon completion of their data collection period, wait-list participants will be offered the full EMBRACE program as an ethical provision given the established benefits of exercise for caregiver mental health.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physical Activity

    Physical activity will be measured by using Actigraph GT3X acclerometers. Specfically the average weekly moderate-to-vigorus physical activity (MVPA) time over the span of two weeks will be the primary outcome and analyzed.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2026
  2. Study start1 Mar 2026
  3. Primary completion1 May 2028 (estimated)
  4. Study completion1 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants in the intervention arm will be prescribed with an exercise program
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07486037
Sponsor's protocol ID
29378
Status last verified
May 2026
First submitted
14 Mar 2026
Last updated
11 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Protect participants confidentiality.

Questions about this trial

What is this clinical trial studying?

A study testing Exercise in people with Intervention Group and Treatment as Usual, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Navin Kaushal, PhD, FACM,FAHA (317 278-9598, nkaushal@iu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physical Activity (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in